2022 Ljubljana, Slovenia

I-61 Paul van den Berg
Finerenone Dose-Exposure-Response for the Primary Kidney Outcome in FIDELIO-DKD Phase III: Population Pharmacokinetic and Time-to-Event Analysis
Wednesday 09:45-11:15